We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Clinical Validation of the Rating Scale for Psychotic Depression (RAS-PD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01518049
Recruitment Status : Completed
First Posted : January 25, 2012
Last Update Posted : October 14, 2015
Information provided by (Responsible Party):

January 21, 2012
January 25, 2012
October 14, 2015
February 2012
September 2013   (Final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT01518049 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
Clinical Validation of the Rating Scale for Psychotic Depression (RAS-PD)
Not Provided

The aim of this study is to develop a scale to measure the severity of depression with psychotic symptoms (psychotic depression). Furthermore, we hope to detect potential biomarkers (substances in the blood) which can aid in the detection of psychotic depression.

Main hypothesis: A clinically valid rating scale measuring the severity of psychotic depression can be developed.

Not Provided
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Retention:   Samples With DNA
blood samples
Non-Probability Sample
inpatients or outpatients at Danish Psychiatric Hospitals fulfilling criteria for unipolar depression with psychotic symptoms.
Affective Disorders, Psychotic
Not Provided
Not Provided
Østergaard SD, Pedersen CH, Uggerby P, Munk-Jørgensen P, Rothschild AJ, Larsen JI, Gøtzsche C, Søndergaard MG, Bille AG, Bolwig TG, Larsen JK, Bech P. Clinical and psychometric validation of the psychotic depression assessment scale. J Affect Disord. 2015 Mar 1;173:261-8. doi: 10.1016/j.jad.2014.11.012. Epub 2014 Nov 18.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
September 2014
September 2013   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Fulfilling ICD-10 criteria DF32.3 or DF33.3
  • At least 18 years old
  • Legally competent
  • Informed consent (oral & written)

Exclusion Criteria:

  • Insufficient Danish Language skills
  • Moderate to severe dementia
  • Abuse of psychoactive substances
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
Contact information is only displayed when the study is recruiting subjects
Not Provided
Not Provided
Søren Dinesen Østergaard, Aarhus University Hospital
Søren Dinesen Østergaard
Not Provided
Principal Investigator: Søren D Østergaard, MD Aahus University Hospital
Aarhus University Hospital
October 2015